Cold Relief Roll-On Market By Product Type (Menthol-based Roll-On, Camphor-based Roll-On, Herbal/Plant-based Roll-On, and Others), By Application (Nasal Congestion Relief, Muscle Pain Relief (related to cold), Headache Relief, and Others), By Distribution Channel (Pharmacies & Drugstores, Supermarkets & Hypermarkets, Online Retail, and Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Report Overview

The Cold Relief Roll-On Market Size is expected to be worth around US$ 1.4 billion by 2034 from US$ 0.6 billion in 2024, growing at a CAGR of 8.8% during the forecast period 2025 to 2034. North America held a dominant market position, capturing more than a 38.2% share and holds US$ 0.2 Billion market value for the year.

Rising global prevalence of seasonal illnesses, such as the common cold and influenza, is a key driver for the cold relief roll-on market. These conditions, characterized by symptoms like nasal congestion, headaches, and muscle aches, are widespread and recurrent. According to the World Health Organization (WHO), seasonal influenza alone causes up to 1 billion cases and between 290,000 to 650,000 respiratory deaths annually, underscoring the immense global burden of these illnesses. Consumers are increasingly seeking convenient, non-oral, and effective remedies for immediate symptomatic relief, positioning cold relief roll-ons as a popular alternative to traditional pills or liquids.

Growing demand for natural and topical healthcare solutions is a significant trend shaping the market. Consumers are increasingly favoring products with natural ingredients like menthol, camphor, and eucalyptus for their soothing and decongestant properties, moving away from pharmaceutical-heavy options. This is further fueled by the desire for easy-to-apply, non-messy products that can be used on the go. Companies are also investing in strategic marketing to reposition their products for broader use.

For instance, in December 2021, Amrutanjan unveiled an advertising campaign for its pain relief products, featuring Olympic medalists Mirabai Chanu and Bajrang Punia. By associating its roll-ons with high-performance athletes, Amrutanjan aimed to broaden the product’s appeal as a versatile solution for various types of pain and congestion.

Increasing accessibility and the rise of e-commerce platforms are creating new opportunities for market expansion. The CDC notes that the average adult gets two to three colds per year, and children get even more, which creates a constant, year-round demand for these products. This consistent need is being met by the wide availability of cold relief roll-ons through online retail channels, which offer convenience and a wide variety of brands. The user-friendly application method of a roll-on, which eliminates the need for direct hand-to-product contact, also appeals to hygiene-conscious consumers, ensuring that the market for these products will continue to see strong growth across various consumer demographics.

Key Takeaways

• In 2024, the market for cold relief roll-on generated a revenue of US$ 0.6 billion, with a CAGR of 8.8%, and is expected to reach US$ 1.4 billion by the year 2034.
• The product type segment is divided into menthol-based roll-on, camphor-based roll-on, herbal/plant-based roll-on, and others, with menthol-based roll-on taking the lead in 2023 with a market share of 45.6%.
• Considering application, the market is divided into nasal congestion relief, muscle pain relief (related to cold), headache relief, and others. Among these, nasal congestion relief held a significant share of 50.4%.
• Furthermore, concerning the distribution channel segment, the market is segregated into pharmacies & drugstores, supermarkets & hypermarkets, online retail, and others. The pharmacies & drugstores sector stands out as the dominant player, holding the largest revenue share of 42.7% in the cold relief roll-on market.
• North America led the market by securing a market share of 38.2% in 2023.

Product Type Analysis

Menthol-based roll-on products hold the largest share of 45.6% in the cold relief roll-on market. This dominance is driven by menthol’s well-known soothing and cooling effects, making it highly effective in alleviating symptoms of nasal congestion and muscle pain. Menthol-based roll-ons are often chosen for their fast-acting, easy-to-use nature and strong market recognition. The growing consumer preference for topical, non-ingestible solutions for cold-related discomfort is expected to continue fueling the growth of this segment. As more people seek quick relief from cold symptoms without the use of oral medications, menthol-based products are likely to remain a top choice.

The segment’s growth is also supported by the increasing awareness of the benefits of menthol in improving respiratory function and reducing muscle soreness. Additionally, product innovations, such as long-lasting formulas and added natural ingredients, are projected to enhance the appeal of menthol-based roll-ons further. This segment is anticipated to continue expanding as consumers demand more effective and convenient over-the-counter remedies for everyday cold symptoms.

Application Analysis

Nasal congestion relief accounts for 50.4% of the application segment in the cold relief roll-on market. The dominance of this application is expected to persist as nasal congestion is one of the most common symptoms of cold and flu, with millions of people seeking relief each year. The ease of use and targeted application of nasal congestion roll-ons make them a popular choice for consumers looking to clear blocked nasal passages quickly. Menthol and other cooling agents commonly used in these products are known to provide immediate relief, making them indispensable during cold and allergy seasons. The growing consumer focus on self-care and the increasing availability of such products in pharmacies and retail outlets are expected to drive further demand.

Additionally, the rising awareness of the importance of respiratory health, especially post-pandemic, is projected to contribute to the growth of this segment. The availability of more advanced nasal congestion relief formulas, with added anti-inflammatory and decongestant properties, will likely enhance the segment’s appeal and market penetration. Nasal congestion relief roll-ons will continue to be a go-to solution for individuals seeking a fast, effective way to relieve blocked noses.

Distribution Channel Analysis

Pharmacies and drugstores represent the largest distribution channel for cold relief roll-ons, with a 42.7% market share. The growth of this segment is largely attributed to the high consumer trust in pharmacies as reliable sources of over-the-counter healthcare products. Pharmacies and drugstores are frequently visited by consumers for quick access to remedies for cold symptoms, making them essential in the distribution of cold relief roll-ons. The ease of availability and the convenience of purchasing from local stores are key drivers of this segment’s growth. As more people seek instant relief for colds, pharmacies and drugstores are expected to expand their range of roll-on products, providing consumers with a wider variety of options for different symptoms.

The steady rise in health-conscious individuals, coupled with increasing cold and flu cases globally, is expected to further propel the demand for such products in these retail outlets. Additionally, the integration of pharmacies with e-commerce platforms is anticipated to increase the visibility of cold relief roll-ons, further enhancing their reach and sales. The expanding role of pharmacies as health hubs and one-stop solutions for wellness products is likely to support the continued growth of this distribution channel in the cold relief roll-on market.

Key Market Segments

By Product Type

• Menthol-based Roll-On
• Camphor-based Roll-On
• Herbal/Plant-based Roll-On
• Others

By Application

• Nasal Congestion Relief
• Muscle Pain Relief (related to cold)
• Headache Relief
• Others

By Distribution Channel

• Pharmacies & Drugstores
• Supermarkets & Hypermarkets
• Online Retail
• Others

Drivers

The rising prevalence of common respiratory illnesses is driving the market

The cold relief roll-on market is experiencing significant growth, primarily driven by the consistent and widespread incidence of upper respiratory infections, such as the common cold and influenza. These conditions are a perennial health concern for consumers, leading to symptoms like nasal congestion, headaches, and chest discomfort.

The convenience and targeted application of roll-on products, which deliver soothing relief directly to the affected areas, make them a popular choice for self-care. The Centers for Disease Control and Prevention (CDC) provides regular updates on the burden of influenza, with its preliminary estimates for the 2023-2024 season indicating an estimated 40 million flu-related illnesses in the United States alone. This high volume of cases, which reflects a return to pre-pandemic levels, creates a sustained and predictable demand for effective and easy-to-use symptom management products, including topical applications.

Restraints

Lack of strong clinical evidence and regulatory scrutiny are restraining the market

A significant restraint on the market is the inherent challenge posed by the limited clinical evidence supporting the efficacy of many natural-ingredient products. While consumers are drawn to the perceived safety and holistic benefits of essential oils, many cold relief roll-ons lack the rigorous, double-blind, placebo-controlled trials that are standard for pharmaceutical drugs. This creates a gap between marketing claims and scientific validation.

Furthermore, regulatory bodies are increasing their scrutiny of efficacy claims for such products. The US Food and Drug Administration (FDA) issued over 15 warning letters in 2022 and 2023 to companies making unsubstantiated claims about their wellness and essential oil products, including some related to cold symptoms. This regulatory pressure and the absence of robust clinical data can create consumer skepticism and limit market expansion, as trust in product effectiveness is a key purchasing factor.

Opportunities

The increasing consumer preference for natural and plant-based ingredients is creating growth opportunities

The market is presented with significant opportunities from a broader consumer trend toward using natural and herbal ingredients in health and wellness products. Consumers are increasingly seeking out products with clean labels, avoiding artificial additives and synthetic compounds. This shift in preference aligns perfectly with the common formulation of many topical cold relief products, which often contain natural ingredients like menthol, eucalyptus, and camphor.

A 2024 survey, a majority of American consumers prefer to use food and natural products to manage their health over prescription medication, a sentiment that extends to the OTC market. This growing desire for plant-based solutions provides a strong tailwind for the development and marketing of new formulations that highlight their natural origins, appealing to health-conscious consumers and positioning the category as a more holistic self-care option.

Impact of Macroeconomic / Geopolitical Factors

The cold relief roll-on market is navigating a complex macroeconomic and geopolitical landscape that affects both consumer purchasing power and the stability of its supply chain. US consumer spending, a key economic indicator, increased by 5.9% in 2023, reflecting strong consumer demand for discretionary items. Geopolitical tensions and trade policies add significant cost pressures on the supply chain.

For example, some topical medicinal preparations are subject to specific import duties. Despite these challenges, the market demonstrates resilience in the face of these headwinds. According to the US Bureau of Labor Statistics, nonprescription drug prices in the US actually declined by 0.3% in 2024, following a previous increase, reflecting the highly competitive nature of the over-the-counter market where manufacturers absorb some costs to maintain market share.

Latest Trends

The development of multi-symptom relief formulas is a recent trend

A significant trend in 2024 is the accelerating development of multi-symptom relief formulas that combine active ingredients to address a wider range of cold symptoms in a single application. Historically, many topical remedies focused on a single issue, such as congestion. The newer products, however, are formulated to provide comprehensive relief from symptoms that often co-occur, such as nasal congestion, sinus pressure, headaches, and minor muscle aches. This approach offers greater convenience for consumers, who no longer need to purchase and apply multiple products to find relief.

According to data from the US Food and Drug Administration (FDA) on new drug approvals, the trend toward combination products is clear. For example, the FDA’s new drug therapy approvals in 2024 included a number of combination products for various conditions, underscoring the shift in the pharmaceutical industry toward more comprehensive, single-product solutions.

Regional Analysis

North America is leading the Cold Relief Roll-On Market

The North American cold relief roll-on market held a commanding 38.2% share of the global market in 2024. This leadership is directly attributed to several key factors, including a high burden of seasonal respiratory illnesses, a growing consumer preference for over-the-counter (OTC) self-care products, and a strong trend toward natural and homeopathic remedies. The US experiences a significant number of flu cases each year, driving a consistent demand for products that alleviate symptoms like congestion and body aches.

For instance, the Centers for Disease Control and Prevention (CDC) estimated that during the 2023-2024 influenza season, there were approximately 40 million illnesses, 470,000 hospitalizations, and 28,000 deaths from the flu in the US alone. This substantial disease burden fuels the demand for convenient, non-oral relief options like roll-ons. The market is also propelled by the increasing availability of these products through a robust e-commerce and retail infrastructure, which caters to the modern consumer’s preference for accessibility and convenience.

The Asia Pacific region is expected to experience the highest CAGR during the forecast period

The Asia Pacific cold relief roll-on market is anticipated to experience the fastest growth during the forecast period. This is largely a result of rapidly increasing health consciousness, a growing middle-class population, and rising disposable incomes. The region’s dense populations and urbanization also contribute to the rapid spread of seasonal respiratory illnesses. According to the World Health Organization (WHO), influenza activity in the Asia Pacific region has been elevated in recent years, with a high percentage of positive tests reported in several countries.

The market’s expansion is further supported by a strong cultural affinity for traditional and natural remedies, which aligns well with the composition of many cold relief roll-ons that contain essential oils and herbal extracts. The increasing availability of products through online channels, combined with targeted marketing campaigns, is likely to make these products more accessible to a broader consumer base and fuel the market’s growth.

Key Regions and Countries

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Russia
  • Netherland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • New Zealand
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of MEA

Key Players Analysis

Key players in the cold relief roll-on market are driving growth through several key strategies. They are heavily investing in product innovation, particularly by incorporating natural, herbal ingredients to appeal to wellness-conscious consumers. Companies are also pursuing aggressive digital marketing and e-commerce expansion to reach a broader, tech-savvy audience and leverage the convenience of online shopping.

Furthermore, they are broadening their product portfolios to offer solutions for a wider range of conditions, such as headaches and stress, effectively increasing their addressable market. This combination of innovative product development and sophisticated marketing is essential for maintaining a competitive edge.

Amrutanjan Health Care Ltd., an Indian pharmaceutical company, has established a dominant position in the congestion management segment. The company’s business model leverages a strong legacy and brand recognition built over a century. Amrutanjan’s strategy involves continuously innovating its flagship products and diversifying into new categories, such as women’s hygiene, while maintaining its core focus on pain and congestion relief. The company’s success is a direct result of its ability to adapt traditional Ayurvedic formulations into modern, convenient delivery systems, solidifying its market leadership and ensuring a steady consumer base in both urban and rural areas.

Top Key Players in the Cold Relief Roll-On Market

• Vicks
• Amrutanjan
• BabyOrgano
• Mamaearth
• Mother Sparsh
• Johnson & Johnson
• Procter & Gamble
• Zydus Lifesciences
• The Himalaya Drug Company
• Cipla Ltd.

Recent Developments

• In March 2024: Vicks launched a new roll-on product for headaches. This product’s release was accompanied by a new television commercial that highlighted its convenience and portability. The product is formulated with high-strength Ayurvedic ingredients like Pudinah (Menthol) and Karpoor (Camphor), which positions it as a modern solution that utilizes traditional components. This strategic expansion into a related ailment like headaches is a significant growth driver.
• In February 2023: BabyOrgano introduced a Natural Cold Relief Roll-On for infants. The company’s focus was on creating a product for a specialized and sensitive consumer segment. The product is made with a blend of essential oils and is specifically formulated to be free from camphor, aligning with the growing demand for natural, safe, and chemical-free options for baby care.

Report Scope